Why the crude-looking cot is a mortality intervention
It is easy to underrate a cholera cot precisely because it looks primitive. The mortality data corrects that instinct. Severe cholera left untreated carries a case-fatality rate of roughly 30 to 50 percent; with prompt and adequate rehydration that figure falls below one percent. The decisive variable in delivering that collapse is accurate fluid replacement — and you cannot replace losses you cannot measure. The cot's central aperture over a calibrated bucket is what turns an estimated stool output into a measured one, which is the clinical basis for the entire rehydration plan in a disease where an adult can lose litres an hour.
The structure around the cot matters just as much. A treatment centre laid out as a clean one-way circuit, with separated corridors and chlorinated drainage away from the wards, is what keeps the under-one-percent figure from being undone by cross-contamination. And the supply picture is fragile: in 2024 the global oral-cholera-vaccine stockpile ran empty, with requests for 8.4 million doses over six weeks only partly met, which means treatment infrastructure — cots, fluids, and circuit design — is carrying more of the response burden, not less. We grade these structures on aperture geometry, drainage, deployment speed, and decontaminability because those properties are, quite literally, where the mortality curve is bent.